Nasdaq

Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries

IRVINE, Calif., July 15, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
Nature

EXPERIMENTAL USE OF A NEW ATRIALLY PASSED, SUTURELESS, VENTRICULAR APEX TO AORTA CONDUIT

Ventricular outflow obstruction in the infant remains a surgical challenge with high operative mortality despite a variety of approaches. An apical to aortic conduit would be a direct approach but ...
Newswire

Edwards KONECT RESILIA Aortic Valved Conduit, MITRIS RESILIA Mitral Valve Receive Health Canada Approval

MISSISSAUGA, ON, July 29, 2021 /CNW/ -- Edwards Lifesciences (Canada) Inc. has announced it received regulatory approval from Health Canada for both the KONECT RESILIA aortic valved conduit and the ...
BioWorld

Items Tagged with 'Konect Resilia aortic valved conduit'

Edwards Lifesciences Corp. has scored an approval from the U.S. FDA for the Konect Resilia aortic valved conduit, a ready-to-implant solution for bio-Bentall procedures.
TCTMD

TVT 1055: Transcatheter Aortic Valve Replacement Followed by Transcatheter Closure of the Apicoaortic Conduit as Treatment for Failing Apicoaortic Conduit in a Patient With ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Nasdaq

Edwards Announces FDA Approval For KONECT RESILIA Aortic Valved Conduit - Quick Facts

(RTTNews) - Edwards Lifesciences Corp. (EW) has received approval from the U.S. FDA for the KONECT RESILIA aortic valved conduit, the first ready-to-implant solution for bio-Bentall procedures. The ...